Olaparib, PARP1 inhibitor in ovarian cancer

Author: Marchetti Claudia   Imperiale Ludovica   Gasparri Maria Luisa   Palaia Innocenza   Pignata Sandro   Boni Terenzio   Bellati Filippo   Benedetti Panici Pierluigi  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.21, Iss.10, 2012-10, pp. : 1575-1584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract